© Copyright - Newspaper WordPress Theme by TagDiv
Levosalbutamol
Also known as / Synonyms: Levalbuterol, R-Salbutamol, Pure R-enantiomer SABA
Single-isomer short-acting beta-2 agonist (SABA) that rapidly relieves acute asthma and COPD bronchospasm with lower heart palpitation risk.
Clinical Snapshot & Specifications
Approved Indications & Medical Uses
- Treatment or prevention of acute bronchospasm in adults and children 4 years of age and older with reversible obstructive airway disease (asthma, COPD).
- Preferred over racemic salbutamol in patients prone to beta-agonist-induced tachycardia, cardiac palpitations, or tremors due to omission of the (S)-isomer.
Contraindications (Do Not Use If…)
- History of hypersensitivity to levosalbutamol, racemic salbutamol, or any excipients.
- Used for tocolysis in threatened abortion or premature labor.
Important Clinical Precautions & Warnings
- Paradoxical bronchospasm: can occur and may be life-threatening; discontinue immediately and institute alternative therapy.
- Cardiovascular effects: can produce clinically significant tachycardia, blood pressure changes, and palpitations, although less frequently than racemic salbutamol.
- Hypokalemia and hyperglycemia: can produce transient reductions in serum potassium and elevations in blood glucose.
- Excessive use: deterioration of asthma requires reassessment of maintenance therapy (e.g., intensifying inhaled corticosteroids), not continuous escalation of bronchodilators.
Special Populations (Paediatric & Geriatric Care)
Pediatric: Approved for nebulization in children >= 4 years. Dosing in infants must be carefully supervised. Geriatric: Start at lower recommended doses due to higher prevalence of underlying cardiovascular disease.
Side Effects & Adverse Reactions
Common Side Effects (Usually Mild)
Fine skeletal muscle tremor, nervousness, headache, dizziness, tachycardia, palpitations, throat irritation, and nausea.
Serious Side Effects — Seek Urgent Medical Care
Severe paradoxical bronchospasm, cardiac arrhythmias, myocardial ischemia, significant hypokalemia, and immediate hypersensitivity reactions (urticaria, angioedema).
Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.
Drug, Food & Substance Interactions
- Non-cardioselective beta-blockers (propranolol): block bronchodilator effect and can produce severe bronchospasm in patients with asthma.
- Potassium-depleting diuretics: co-administration can potentiate acute hypokalemia.
- Digoxin: may produce modest decreases in serum digoxin levels; monitor digitalis concentrations.
- MAO inhibitors and tricyclic antidepressants: potentiate cardiovascular actions on vascular tone.
Pregnancy & Lactation Clinical Safety
Pregnancy Safety:
Use with caution — see notesClinical data on levalbuterol in pregnant women are limited. Albuterol has extensive human experience without evidence of teratogenicity. It should be used during pregnancy only if the potential benefit justifies potential fetal risk.
Lactation & Breastfeeding:
Use with caution — see notesIt is not known whether levosalbutamol is excreted in human milk. Exercise caution when administering to a nursing woman.
Storage, Administration & Overdose Protocol
🌡️ Recommended Storage:
Store MDI canister at 20°C to 25°C (68°F to 77°F). Do not puncture or incinerate pressurized canister. Store nebulizer respules in original foil pouch to protect from light.
⏱️ Missed Dose Protocol:
Take as needed for acute shortness of breath. If prescribed on a scheduled regimen, take as soon as remembered unless close to the next dose. Never double puff.
Overdose produces pronounced tremor, extreme tachycardia, palpitations, chest pain, seizures, hypokalemia, and metabolic acidosis. Discontinue immediately; supportive therapy with cardioselective beta-blockers may be considered with extreme caution.
Clinical Sources & Regulatory References
Statutory drug monograph citations and regulatory databases consulted for clinical synthesis.
Every clinical monograph on 4mg.in is continuously cross-referenced against official pharmacopoeias, national formulary compendia, and statutory regulatory filings to guarantee therapeutic precision:
Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare. Evaluated for approved indications, Schedule H/H1 status, and National List of Essential Medicines (NLEM).
CDSCO Official Portal →U.S. Food and Drug Administration Approved Prescribing Information, Package Inserts, and Pharmacovigilance Black Box Warnings repository via NLM DailyMed.
Search FDA Labels on DailyMed →WHO Model List of Essential Medicines (23rd List) and WHO Collaborating Centre for Drug Statistics Methodology (Anatomical Therapeutic Chemical - ATC / DDD Index).
WHO Essential Medicines Registry →National Center for Biotechnology Information (NCBI). Peer-reviewed clinical trials, bioavailability investigations, and Cochrane systematic reviews.
Query PubMed Studies for Levosalbutamol →
4mg Clinical Pharmacology Team. Levosalbutamol Monograph: Uses, Dosage, Contraindications & Interactions. Medically reviewed by licensed clinical editors. 4mg.in, 2026. Available at: https://4mg.in/medicines/levosalbutamol/
